Deepay Mukerjee is a management consultant and university Executive MBA instructor based in Charleston, WV.
Most recently, Mukerjee served as the President and COO of Progenesis, a premier technology company developing innovative polymers, utilizing genetic engineering as the core platform technology. Progenesis explored strategic alliances with companies in China, Europe and Latin America for the distribution of its products worldwide.
Prior to this, Mukerjee was the President & CEO of National Institute for Chemical Studies (NICS). NICS is headquartered in Charleston, West Virginia, and is known internationally for conducting research, education and outreach to manage the environmental, health and safety risks associated with a variety of different chemicals. NICS was instrumental in bringing diverse stakeholders together with its neutral, unbiased approach. Mukerjee brings in extensive experience from chemical, biopharmaceutical, and technology industries.
Prior to NICS, Mukerjee was the President & CEO of PharmX, Inc., based in Portland, Maine. PharmX is a biopharmaceutical company that utilizes alternate delivery technology as its core platform technology. During his Presidency at PharmX, he received the Maine Technology Institute’s Innovation award in 2002. Prior to joining PharmX, Mukerjee was the President of RF Technologies Corporation (1994-2001), where he and his team developed and launched the world’s first automated continuous chemical processing system with microwave technology, which even today remains the only viable system worldwide. The financial performance of RFT and expansion of RFT markets internationally (Japan, Germany & India) during this period earned him the Blue Chip Enterprise award in 1998. In 1994, Mukerjee negotiated a multi-million dollar contract with China (the first one of this size from the State of Maine). RFTechmologies was an outcome of an investment banking deal with Firstmark, where Mukerjee served as its President for 3 years.
Earlier in his career, Mukerjee managed several specialty chemical businesses at the Division level within BFGoodrich Chemical Company (Ohio) in pharmaceuticals, personal care and industrial markets. Mukerjee helped BFGoodrich penetrate international markets (Japan, India, China and Brazil) in several areas and co-developed innovative new products introducing a breakthrough technology. Prior to joining BFGoodrich, Mukerjee spent 7 years at Clobar Manufacturing (New York) in their R&D and manufacturing. At Clobar, Mukerjee was instrumental in innovating new products competing against textile giants of the world.
Mukerjee holds an MBA from Cleveland State University (Ohio) in Finance and Marketing, and is a Beta Gamma Sigma (MBA honor society) member. He also has an MS from Clarkson University (New York) and a B. Tech (Hons.) from Indian Institute of Technology (India) in Chemical Engineering with national scholarship. He has co-authored 2 US patents and taught Executive MBA courses at the University of Charleston (WV) and University of New Hampshire. He has served on several Boards and served as an executive committee member in various trade associations like AIChE, CMA, ACS IMPI and others. During his spare time he coached debate high school teams and served as a judge at national debate competitions. He also enjoys bridge, golf, tennis and traveling.
